Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From Fear to Purpose ACT Protocol: Testing Indirect, Transdiagnostic Implications of Death Anxiety Over Depression and Anxiety. A Randomized Placebo Controlled Trial.

NCT06810999 is registered in ClinicalTrials.gov with Babes-Bolyai University as lead sponsor.

NCT NCT06810999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06810999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From Fear to Purpose ACT Protocol: Testing Indirect, Transdiagnostic Implications of Death Anxiety Over Depression and Anxiety. A Randomized Placebo Controlled Trial.
Lead sponsor
Babes-Bolyai University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
December 30, 2025
Enrollment
175 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, death anxiety, depression